Trump NIH Caps Research University Overhead At 15 Percent On A Friday Night, Sparing American Biomedical Research From Further Imposition Of Cures

The Filing

WASHINGTON. The National Institutes of Health on Friday evening issued new guidance capping the indirect cost rate paid to research universities at 15 percent, a reduction from negotiated rates of between 50 and 70 percent that the agency described as a long-overdue alignment with private foundation practice, and that university administrators described as the immediate elimination of roughly four billion dollars in annual biomedical research support.

The new rate, which the NIH instructed would apply to all new awards immediately and to existing grants going forward, took effect over the weekend, giving the nation's leading research institutions a window of approximately 36 hours to restructure their entire fiscal models. Indirect costs, which fund the operating expenses associated with research (laboratory space, animal care, hazardous waste disposal, regulatory compliance, IT systems, and the support staff who keep grant-funded labs functional), had previously been negotiated institution by institution, with research-intensive universities reaching higher rates because they conduct higher-overhead research.

Harvard, Johns Hopkins, Stanford, MIT, the University of California system, and dozens of state flagship universities were projected to lose between 100 million and 500 million dollars each in annual support under the new rate. "The President has made clear that the elite universities will not be permitted to continue collecting federal research dollars while teaching ideas the administration disagrees with," said one administration source familiar with the policy. The source declined to specify which ideas were objectionable, but confirmed that the 15 percent figure had been arrived at through a process the source described as "a number the President liked."

A federal judge in Massachusetts enjoined the policy within five days, finding that the NIH had violated both the Administrative Procedure Act and the explicit terms of statutes Congress had passed prohibiting unilateral changes to indirect cost rates, a development that allowed the administration to characterize the policy as a successful demonstration of its commitment to confronting unelected judges. The substantive effect survived the injunction. Major research universities, anticipating that the policy or some variation would eventually be reimposed, and observing that the Department of Government Efficiency was simultaneously freezing already-awarded NIH grants, paused new hiring, cancelled scheduled postdoctoral appointments, suspended ongoing clinical trials, and instructed faculty to refrain from accepting new doctoral students. The American Cancer Society estimated that more than 4,000 active cancer research projects had been affected within the first month.

At press time, the President was reviewing whether to similarly cap indirect cost rates paid by the National Science Foundation, the Department of Defense, and NASA, on the principle that federal money was best preserved by not being spent on anything in particular.

Who Benefits

§President Donald J. Trump, who delivered a long-promised punitive deliverable against the Ivy League institutions whose admissions practices and faculty politics he has publicly resented for decades, all without the inconvenience of legislation.
§Project 2025 contributors and the Heritage Foundation, whose chapters on higher education and federal research funding received a high-visibility executive endorsement five weeks into the administration.
§The Department of Government Efficiency under Elon Musk, which paired the NIH guidance with a parallel grant freeze, allowing a private actor with no congressional confirmation to effectively determine the operating budgets of every major American research university.
§Foreign research programs in China, the United Kingdom, Germany, and Canada, which began aggressively recruiting American researchers within days and which numerous American faculty publicly confirmed they were taking up.
§Pharmaceutical companies, which now face a future research pipeline more heavily dependent on private industry funding and, accordingly, more responsive to the priorities of pharmaceutical companies.
§The Federalist Society and conservative legal advocacy groups, which gained an opportunity to litigate the limits of the Administrative Procedure Act against an administration that had already committed to ignoring adverse rulings.
§The President's stated political enemies at named universities, who acquired the moral standing of besieged institutions, a position several were observed using to raise record alumni donations during the spring term.

Sourced to the public record · presented without editorial embellishment